Home > Boards > US OTC > Cannabis >

Cannabix Technologies Inc. (BLOZF)

BLOZF RSS Feed
Add BLOZF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3, JohnCM, wavetrader8x
Search This Board: 
Last Post: 3/5/2021 3:23:10 PM - Followers: 329 - Board type: Free - Posts Today: 6






Cannabix Technologies Inc.

(CSE: BLO    US OTC: BLOZF    
Frankfurt: 8CT:FRA)
 

Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.


Cannabix Technologies Inc. has
Worldwide Rights to
"
Partial ovoidal FAIMS electrode"
Patent 8,237,118
from the University of Florida

WORLDWIDE RIGHTS
for 

CONTROLLED SUBSTANCE

Rights for 10 Years after 1st Product sold



What is FAIMS-MS?


It Blocks Out Unwanted Molecules
 Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost

https://www.msacl.org/index.php?header=Learning_Center&tab=Video_Management&subtab=Video_Request&id=8&conference=2015_US&type=plenary

 
 
US Patent Application
http://www.freshpatents.com/-dt20151029ptan20150305651.php


APPLIED 2014 GRANTED 2021


Canada Patent Application
http://www.ic.gc.ca/opic-cipo/cpd/eng/patent/2887841/summary.html?query=Cannabix&start=1&num=50&type=basic_search
 

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing 


http://www.cannabixtechnologies.com/

 
Outstanding Shares
105,124,104
10/06/2020
 100,567,054
 05/05/
2018
 
Cannabix Corporate Video
https://www.youtube.com/watch?v=ix3Uss9zrBo
Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.


Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

 
Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 





 
BLOZF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BLOZF News: Cannabix Technologies Develops Version 3.0 of THC Breath Analyzer Device 02/25/2021 08:45:00 AM
BLOZF News: Cannabix Technologies Granted U.S. Patent - Cannabis Drug Detection Device 01/12/2021 05:45:00 AM
BLOZF News: Cannabix Technologies to Beta Test Marijuana Breathalyzer with Occupational Health Clinic in Southern California to Meet 11/23/2020 08:45:00 AM
BLOZF News: Cannabix Technologies Receives Notice of Allowance for Cannabis Drug Detection Device U.S. Patent 10/28/2020 07:45:00 AM
BLOZF News: Cannabix Achieves New Plateau with its FAIMS Marijuana Breathalyzer Technology 10/05/2020 08:45:00 AM
PostSubject
#26885  Sticky Note POLITICS-.Chuck Schumer Says Marijuana Reform Bills Are Being drt1111 01/29/21 04:36:08 PM
#26797  Sticky Note Cannabix Technologies Granted U.S. Patent - Cannabis Drug shell3 01/12/21 09:28:57 AM
#27002   Yea i dont remember the exact amount but Anonymoose 03/05/21 03:23:10 PM
#27001   Hi Shell! Great to see you on here!! Mauser866 03/05/21 12:10:06 PM
#27000   I'm not afraid of this dip. There's no RP1983 03/05/21 11:30:02 AM
#26999   Adding to my position each week wavetrader8x 03/05/21 10:36:59 AM
#26998   JMO — The Keys to the Car shell3 03/05/21 09:51:10 AM
#26997   Outstanding: 112,379,104 for March 5, 2021 Monthly Report shell3 03/05/21 09:18:45 AM
#26996   This stock has been a joke for more Flyerpf64 03/04/21 05:21:54 PM
#26995   Becoming quite a joke here. StevenRisk 03/03/21 11:54:25 AM
#26994   I'm in with just 400 shares. Not a OLZEKE 02/27/21 11:55:23 AM
#26993   As well, Here Too Shell...this board was Carthnel 02/25/21 05:46:13 PM
#26992   Foreign.. Canadian company trading on the OTC... AkA.. Lowersioux5 02/25/21 04:59:21 PM
#26991   Anybody know the reason for the F on sambeaux 02/25/21 02:07:58 PM
#26990   Just another bullshit news release. This is getting Fusiontech 02/25/21 11:56:26 AM
#26989   4C - Thanks. I was a Driving Force sambeaux 02/25/21 11:34:25 AM
#26988   It tests for active THC / recent use. 4C 02/25/21 11:20:55 AM
#26987   "7117" is the new 420: www.renocitizen.com/pot.htm sambeaux 02/25/21 11:08:25 AM
#26986   NOW we are onto something! I have Ragstoriches465 02/25/21 11:03:08 AM
#26985   I agree — Well Done shell3 02/25/21 10:48:06 AM
#26984   HIGHER $BLOZF $5 this time shell3 02/25/21 10:44:53 AM
#26983   NICE call High420 !!! Make sure you Grey Ghost 001 02/25/21 10:13:23 AM
#26982   No just obsessive about this stock. This is Carthnel 02/25/21 09:41:50 AM
#26981   Are you an insider??? Fusiontech 02/25/21 09:40:24 AM
#26980   HERE WE GO...to mars! drt1111 02/25/21 09:35:23 AM
#26979   Cannabix Technologies Develops Version 3.0 of THC Breath euroconversions 02/25/21 09:02:19 AM
#26978   Spot on High420! DBLIVEGONZO 02/25/21 08:57:57 AM
#26977   From credible source..news will be out before market High420 02/24/21 09:18:47 PM
#26976   Long and strong, here. Watching how some of RP1983 02/19/21 01:59:13 PM
#26975   Looking forward to that news release that contains Carthnel 02/19/21 08:51:22 AM
#26974   PERSEVERANCE lands on MARS - Come on $BLOZF shell3 02/18/21 03:58:09 PM
#26973   Come on man. Climb. Anonymoose 02/18/21 01:38:50 PM
#26972   Nope, I’m wrong! We’re still up YTD, RP1983 02/18/21 10:48:28 AM
#26971   Yes, I agree with you, monthly chart is wavetrader8x 02/17/21 05:37:23 PM
#26970   I hope I'm right, but $1.38 - $1.40 RP1983 02/17/21 11:59:26 AM
#26969   I renember i positioned myself 3 days before Anonymoose 02/16/21 05:18:30 PM
#26968   2.95 was the High.. for a brief moment. Lowersioux5 02/16/21 02:24:28 PM
#26967   Not in U$D Carthnel 02/16/21 06:10:41 AM
#26966   U guy remember when this hit 3.30? Anonymoose 02/15/21 10:21:40 PM
#26965   Yes, Sir last year . Something has got Carthnel 02/12/21 12:44:21 PM
#26964   That was from 2020 HealthMngr 02/12/21 11:32:40 AM
#26963   Looking to go green today after shaking out gamechanger101 02/12/21 10:55:46 AM
#26962   Nice shell3 02/12/21 10:45:32 AM
#26961   I have no idea, I couldn't find anything Ragstoriches465 02/12/21 09:49:19 AM
#26960   Or was that last year on Tuesday... nice Carthnel 02/12/21 09:49:06 AM
#26959   I wonder why this did not hit my Carthnel 02/12/21 09:47:24 AM
#26958   https://www.theglobeandmail.com/investing/markets/stocks/BLO-CN/pressreleases/43 Ragstoriches465 02/12/21 08:50:38 AM
#26957   Why it did look odd this morning 100k Carthnel 02/11/21 11:05:57 AM
#26956   HALTED>>> drt1111 02/11/21 10:01:22 AM
#26955   HALTED>>> drt1111 02/11/21 10:01:19 AM
#26954   Looks like some Premarket trading! No price change...looking Carthnel 02/11/21 08:55:22 AM
#26953   Looking good! wavetrader8x 02/10/21 08:16:53 PM
PostSubject
Consent Preferences